Shanghai First Maternity and Infant Hospital Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2016
NCT02932761
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Shanghai first maternal and infant hospital

Active Ingredients

Drugs in Phase 1 Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Drugs in Other Trials (1)

goserelin (zoladex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenomyosis (Phase 1)

Premature Birth (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2